Merry Christmas and Happy New Year!
OncoHelper AI is inviting applications and expressions of interest for the role of Chief Oncologist. We are looking for a senior oncologist based in the United States, active or emeritus, who is interested in guiding the clinical direction of our projects and helping us build partnerships with hospitals and cancer centers. Candidates and colleagues who would like to discuss this role are welcome to contact us through the Collaborate form on our website.
We are currently working to identify the lead investigator for our Risk-Adaptive Therapy for Pediatric Oncology project. Over the coming weeks we expect to confirm a project leader and give this initiative a new momentum, as we begin assembling an international clinical and research team around it.
Today OncoHelper AI is launching a new project on curable hereditary anemias in children, a field where data from high risk, low and middle income regions is still very limited. We are now forming the core clinical and research team for this work and are open to collaborators. As soon as the team is in place, the project will move into full development.
Today, the core team for the PARP1-inhibitor project has been reassembled. This group includes the specialists who originally launched the initiative and know its foundations well. With the primary team now in place, the project is moving into its next phase of full-scale development.
